Mariam Alexander

Mariam Alexander practices at MUSC University Hospital in Charleston, South Carolina.

Mariam Alexander's NPI, 1679987382, was assigned on June 20, 2014. Mariam Alexander holds South Carolina license 83619.

Mariam Alexander's primary practice is MUSC University Hospital, at 171 Ashley Ave, Charleston, SC 29425 in Charleston County. The practice phone is (843) 792-1414.

Mariam Alexander's primary practice is MUSC University Hospital in Charleston, South Carolina. Mariam Alexander is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Mariam Alexander to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mariam Alexander practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Mariam Alexander's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Mariam Alexander is licensed in South Carolina.

CMS data shows 716 Medicare services from Mariam Alexander across 6 procedure codes in 2024, for 170 Medicare patients. Medicare paid $42,074 for them.

CMS counts 170 Medicare patients who saw Mariam Alexander in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have cancer, and 73% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mariam Alexander's median patient age at 69, with 60% women.

In 2024, Mariam Alexander wrote 571 Medicare Part D claims for 125 patients. 78% of them were for generic drugs. CMS names the drug for 389 of them, across 15 drugs with 11 or more claims each, at $834,797 in total drug cost. In 2023, CMS named 445 claims across 17 drugs.

Mariam Alexander accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mariam Alexander as offering telehealth.

Dmand AI links 11 papers to Mariam Alexander, published from 2019 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Biomarkers, Tumor. Mariam Alexander's most frequent co-authors are Balazs Halmos, MD, Joshua Michael Bauml, MD and Henny H. Billett, MD.

Dmand AI links Mariam Alexander to 7 clinical trials, 2 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Carcinoma, Bronchogenic. National Cancer Institute (NCI) sponsors the most, 4. Open Payments lists research payments to Mariam Alexander that name 2 trials.

CMS Open Payments shows 25 general payments to Mariam Alexander from 10 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 97% of the total. Janssen Pharmaceuticals, Inc paid the most, $7,515. It also lists 4 research payments totaling $1,048 from 2023 to 2024, naming 2 clinical trials.